GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (FRA:XCY) » Definitions » Cyclically Adjusted Revenue per Share

OPKO Health (FRA:XCY) Cyclically Adjusted Revenue per Share : €1.66 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is OPKO Health Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OPKO Health's adjusted revenue per share for the three months ended in Mar. 2024 was €0.226. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.66 for the trailing ten years ended in Mar. 2024.

During the past 12 months, OPKO Health's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of OPKO Health was 57.00% per year. The lowest was -3.90% per year. And the median was 24.90% per year.

As of today (2024-05-14), OPKO Health's current stock price is €1.16. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.66. OPKO Health's Cyclically Adjusted PS Ratio of today is 0.70.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 118.53. The lowest was 0.48. And the median was 4.90.


OPKO Health Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted Revenue per Share Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.98 1.35 1.54 1.72

OPKO Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 1.62 1.68 1.72 1.66

Competitive Comparison of OPKO Health's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.



OPKO Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.226/129.4194*129.4194
=0.226

Current CPI (Mar. 2024) = 129.4194.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.042 100.560 0.054
201409 0.036 100.428 0.046
201412 0.048 99.070 0.063
201503 0.062 99.621 0.081
201506 0.082 100.684 0.105
201509 0.247 100.392 0.318
201512 0.467 99.792 0.606
201603 0.479 100.470 0.617
201606 0.571 101.688 0.727
201609 0.481 101.861 0.611
201612 0.282 101.863 0.358
201703 0.446 102.862 0.561
201706 0.462 103.349 0.579
201709 0.369 104.136 0.459
201712 0.243 104.011 0.302
201803 0.370 105.290 0.455
201806 0.403 106.317 0.491
201809 0.382 106.507 0.464
201812 0.340 105.998 0.415
201903 0.336 107.251 0.405
201906 0.342 108.070 0.410
201909 0.354 108.329 0.423
201912 0.324 108.420 0.387
202003 0.299 108.902 0.355
202006 0.418 108.767 0.497
202009 0.567 109.815 0.668
202012 0.635 109.897 0.748
202103 0.715 111.754 0.828
202106 0.568 114.631 0.641
202109 0.503 115.734 0.562
202112 0.545 117.630 0.600
202203 0.453 121.301 0.483
202206 0.411 125.017 0.425
202209 0.242 125.227 0.250
202212 0.233 125.222 0.241
202303 0.295 127.348 0.300
202306 0.326 128.729 0.328
202309 0.223 129.860 0.222
202312 0.222 129.419 0.222
202403 0.226 129.419 0.226

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


OPKO Health  (FRA:XCY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.16/1.66
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 118.53. The lowest was 0.48. And the median was 4.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OPKO Health Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (FRA:XCY) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

OPKO Health (FRA:XCY) Headlines

No Headlines